QUESTION TWO [20] Read the scenario below and answer the question that follows: MediLink Research is a global clinical trial organisation conducting vaccine testing in multiple developing countries. While the company meets formal consent requirements, field reports show that participants often do not understand the medical risks due to language barriers and lack of formal education. MediLink compensates them with small stipends and food parcels, which local ethics observers argue could unduly influence consent. Internal emails reveal that the companys legal team approved these procedures as compliant but aggressive. Although the board signed off on ethics documentation, they ignored calls for community review boards and long-term patient monitoring. Public concern intensified after trial results were commercialised into a drug priced far beyond the reach of participants. Human rights groups now question the legitimacy of MediLinks ethical review process and call for greater accountability in cross-border medical research. Analyse the ethical shortcomings in MediLinks consent and pricing practices and recommend how corporate governance and international ethics standards can ensure fairness in medical research.